InvestorsHub Logo
icon url

abuhafsa

03/16/18 11:59 AM

#59776 RE: kyndiloh1 #59773

At some point the science must win. At some point BP and institutions should realize the gem that is ADXS and the incredible price at which it can be acquired. Why isn't that happening? Are BP folks that dumb? I am sure they have many 'hovacres' on their payroll to research exactly these types of acquisitions. Why aren't they seeing what we're seeing and buying hand over fist?

It's all quite puzzling.
icon url

hdwrsft

03/16/18 12:52 PM

#59779 RE: kyndiloh1 #59773

The NEO approach is absolutely noteworthy!

Years ago, what was touted as the "next frontier of immunotherapy," is now here.

Maybe the trojan horse will finally get off its wooden arse and do something NEO-newsworthy, like getting a segment on CNN to get the word out that we have a UNIQUE AND innovative NEO approach like NO other biotech!!!!

In fact, AFTER that first patient dosed, let's make some frigging headlines.

Id be PR'ing the living shyt outta NEO...from the desserts of the sahara to the frozen artic....even the penguins would know about our NEO approach.

NEO dosing is worth double digits, imo.

The fact that we even got this far with all the mgmt turmoil is incredible and worth triple that amount.

Its friday and happy hour cant come too soon....AND my first cocktail will be a NEOpolitan!

Geez.